| Ytd | 30.01% | |
| 1y | 2.70% |
| Open | 30.05 | Prev Close | 30.18 | Low | 30.05 | High | 30.77 | Mkt Cap | 6.19B |
| Vol | 6.29M | Avg Vol | 6.47M | EPS | -2.36 | P/E | N/A | Forward P/E | 36.12 |
| Beta | 1.77 | Short Ratio | 1.44 | Inst. Own | 99.30% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-28 | 50-d Avg | 28.57 | 200-d Avg | 24.91 | 1yr Est | 31.87 |
CZR, RNAC and NSP have been added to the Zacks Rank #5 (Strong Sell) List on July 1, 2026.
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Rachel Cruze warns sports betting and quick-rich schemes are hurting young adults’ long-term financi
Anthony Pompliano said Americans wagered twice as much on sports betting last year as Amazon generat
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Stifel analyst Steven Wieczynski downgrades Caesars Entertainment (NASDAQ:CZR) from Buy to Hold a
https://www.cftc.gov/PressRoom/PressReleases/9249-26
Wells Fargo analyst Trey Bowers maintains Caesars Entertainment (NASDAQ:CZR) with a Equal-Weight
Macquarie analyst Chad Beynon downgrades Caesars Entertainment (NASDAQ:CZR) from Outperform to Ne
Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Resident
Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price tar
Deutsche Bank analyst Carlo Santarelli downgrades Caesars Entertainment (NASDAQ:CZR) from Buy to